Source: MarketScreener

PAION: PAION receives UK MHRA approval of Byfavo (remimazolam) for the induction and maintenance of general anesthesia in adults

(marketscreener.com) EQS-News: PAION AG / Key word: Regulatory Approval PAION receives UK MHRA approval of Byfavo® for the induction and maintenance of general anesthesia in adults 31.08.2023 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. PAION receives UK MHRA approval of...https://www.marketscreener.com/quote/stock/PAION-AG-462044/news/PAION-receives-UK-MHRA-approval-of-Byfavo-remimazolam-for-the-induction-and-maintenance-of-genera-44743183/?utm_medium=RSS&utm_content=20230831

Read full article »
Annual Revenue
$5.0-25M
Employees
25-100
Tilmann Bur's photo - CEO of PAION

CEO

Tilmann Bur

CEO Approval Rating

90/100

Read more